Next Generation Sequencing Testing (NGS)

A Addendum Notice
by NHS BLOOD AND TRANSPLANT

Source
Find a Tender
Type
Contract (Services)
Duration
1 year
Value
£600K
Sector
TECHNOLOGY
Published
26 Jan 2026
Delivery
01 Apr 2026 to 31 Mar 2027
Deadline
20 Feb 2026 12:00

Related Terms

Location

Bristol:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Renewal Options

One (1) year optional extension

Award Criteria

Quality _
Social Value _
Price _

CPV Codes

  • 72225000 - System quality assurance assessment and review services

Indicators

  • Options are available.
  • Renewals are available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Extension to deadline.

Reference

  • ocds-h6vhtk-0514f8
  • FTS 006523-2026

Domains